Mo, Yunyan, et al. “Effectiveness and Safety of Anlotinib With or Without S-1 in the Treatment of Patients With Advanced Hepatocellular Carcinoma in Chinese Population: A Prospective, Phase 2 Study”. Radiology and Oncology, vol. 57, no. 3, Sept. 2023, pp. 405-10, https://radioloncol.com/index.php/ro/article/view/4122.